logo
Preterm Birth Predicts Adult Health Problems

Preterm Birth Predicts Adult Health Problems

Medscapea day ago
Adults born preterm were significantly more likely to have cardiometabolic risk factors and internalized mental health issues than full-term peers, according to an ongoing preterm birth cohort study in the US.
'This study addresses a significant gap in understanding the long-term health effects of preterm birth in the US,' said lead author Amy D'Agata, PhD, of the College of Nursing, The University of Rhode Island, Kingston, Rhode Island, in an interview.
Although the annual preterm birth rate in the US has held at a relatively stable 10%-12% for decades, since the 1970s, more preterm infants are surviving because of advances in neonatal intensive care, D'Agata said. Millions of individuals born preterm are aging into adulthood, but few data are available on their long-term health outcomes, she noted.
In the new study, published in JAMA Network Open , D'Agata and colleagues reviewed data from a cohort of individuals who received level III neonatal intensive care at a single center between 1985 and 1989. The study population included 158 preterm-born and 55 full-term born adult control individuals.
Preterm was defined as weighing under 1850 g at birth with various neonatal diagnoses; critically ill infants and those with major congenital abnormalities were excluded. The mean age across the groups was 35 years; 50% were women. The researchers used latent growth curve models to show changes over time.
Overall, the preterm individuals who had higher medical risk in early life were significantly more likely to have a range of health problems at 35 years of age, notably, higher triglycerides than control individuals (beta value, 53.97; P = .03).
Measures of systolic blood pressure and central adiposity also were significantly higher in the preterm birth group (beta values of 7.15 and 0.22, respectively), whereas bone density and high-density lipoprotein cholesterol were lower (beta values of -1.14 and -13.07, respectively).
In addition, internalizing mental health problems were significantly more common in the preterm cohort than in the control individuals (beta value, 0.85; P = .01) but no difference in externalizing mental health problems was noted between the groups.
The researchers also reviewed the impact of social protection and childhood socioeconomic status and found no association between these and physical or psychological health risks in adults born preterm.
The Long View of Preterm Birth
The population of adults born preterm remains largely invisible to the US healthcare system and its clinicians, highlighting critical issues of health equity and quality of care, D'Agata told Medscape Medical News .
'Much of the existing research in this area has focused on international, homogeneous populations, creating a need for rigorous, US-based longitudinal data to guide healthcare policy and clinical practice,' she added.
'These findings generally confirmed what has been observed internationally, that there is a link between higher early life medical risk and increased likelihood of mental health issues, elevated systolic blood pressure, unfavorable cholesterol and triglyceride levels, body fat distribution, and lower bone density among adults born preterm, and it was notable to see these clear and consistent associations replicated in a US cohort using a prospective, longitudinal design,' said D'Agata.
The study findings emphasized the need to inquire about birth history in adult care settings and suggest that those born preterm and their families must be their own health advocates, if necessary, said D'Agata. 'Even if a patient isn't asked about their birth history, they should share it,' she noted. Clinicians work hard to provide the best care, but it takes time for evidence-based research to inform clinical practice, she said.
'Although our birth cohort is small and comes from a single geographic region, the results generally align with international findings,' D'Agata told Medscape Medical News . However, future studies should include more racially and ethnically diverse cohorts from multiple clinical settings, she said. Research is needed not only to examine which subgroups of preterm individuals are most at risk but also to differentiate between those with varying degrees of early life complications, she added.
Long Follow-Up Strengthens Findings
The 35-year duration of the preterm birth cohort study was impressive and valuable, said Tim Joos, MD, a clinician with a combination internal medicine/pediatrics practice at Neighborcare Health in Seattle. 'We don't often have the long game in mind, in healthcare as well as in other parts of our society,' said Joos, who was not involved in the study. 'We don't tend to follow pediatric conditions into adulthood,' he noted.
The current study findings demonstrated a long-term psychological and physical impact of prematurity on adult health that was humbling, Joos told Medscape Medical News . Looking ahead, the results highlight not only the need to continue to prevent preterm birth but also to the importance of asking older patients about preterm birth as part of their health history, he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

W Health Ventures Launches USD70M Fund II to Build New-Age Healthcare Startups in India
W Health Ventures Launches USD70M Fund II to Build New-Age Healthcare Startups in India

Entrepreneur

timean hour ago

  • Entrepreneur

W Health Ventures Launches USD70M Fund II to Build New-Age Healthcare Startups in India

The fund aims to back 8 to 10 new ventures over the next four years You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Early-stage investor W Health Ventures has launched its second fund worth USD 70 million, doubling down on its unique company-creation model to build healthcare startups from scratch in India. The fund aims to back 8 to 10 new ventures over the next four years, with a focus on single-specialty care platforms and AI-enabled healthcare services. The launch comes at a time when India's USD370 billion healthcare sector is undergoing transformation, with rising demand for quality, patient-centric care and increasing global interest in Indian healthcare products and services. Despite the growth, healthcare remains a difficult sector to crack for startups, given the regulatory, clinical, and relationship-driven complexities. W Health Ventures hopes to bridge this gap through an active incubation model in partnership with 2070 Health, India's first healthcare venture studio. The firm plans to embed startup infrastructure, a platform team, and strategic capital from the ground up. "Healthcare innovation in India remains 10-15 years behind global benchmarks. This gap is a generational opportunity," said Dr. Pankaj Jethwani, Managing Partner at W Health Ventures. "That is why, over the past five years, we have built the infrastructure to identify white spaces, partner with exceptional founders, and accelerate their journey through proven playbooks, anchor customers, and a seasoned platform team." W Health's first fund backed 12 companies that collectively serve more than 25 million patients worldwide. Its portfolio includes startups like BeatO (diabetes), Mylo (parenting), BabyMD (paediatrics), and AI-driven platforms such as Wysa and Reveal HealthTech. With Fund II, the firm is sharpening its focus on two tested themes: specialty care platforms that address critical clinical gaps in India, and B2B healthcare services leveraging AI and Indian clinical-engineering talent to serve US-based firms. The firm has already started deploying capital from the new fund. One of its first investments, EverHope Oncology, was founded to rethink cancer care in India by offering advanced diagnostics, therapies, and outpatient treatment spaces closer to patients' homes. The startup received a USD10 million day-zero investment led by Narayana Health.

US Senate Confirms Susan Monarez as Director of the CDC
US Senate Confirms Susan Monarez as Director of the CDC

Bloomberg

time9 hours ago

  • Bloomberg

US Senate Confirms Susan Monarez as Director of the CDC

The US Senate confirmed President Donald Trump's nominee to lead the US Centers for Disease Control and Prevention on Tuesday, as the federal agency adjusts to widespread layoffs and cancellations of public health programs. Susan Monarez will take the helm as director of the Atlanta-based CDC following a 51 to 47 vote, after Republicans rallied behind the president's pick. She was the acting director when Dave Weldon, Trump's original choice, was abruptly pulled after members expressed concerns over his vaccine views.

AstraZeneca's US Investment, Future of Psychedelic Therapy
AstraZeneca's US Investment, Future of Psychedelic Therapy

Bloomberg

time11 hours ago

  • Bloomberg

AstraZeneca's US Investment, Future of Psychedelic Therapy

On today's episode of Bloomberg Businessweek Daily with Tim Stenovec and Carol Massar, Pascal Soriot, Chief Executive Officer of AstraZeneca discusses the company's quarterly earnings. Kabir Nath, Chief Executive Officer of Compass Pathways, on the pursuit of FDA approval of the first psychedelic treatment for certain people living with depression. Also, Bloomberg's Molly Smith and Oliver Crook on US-China Trade talks and the FOMC meeting (Source: Bloomberg)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store